Carson Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Buy |
2,709
+256
| +10% | +$47.5K | 0.32% | 73 |
|
|
2025
Q1 | $514K | Sell |
2,453
-25
| -1% | -$5.24K | 0.35% | 70 |
|
|
2024
Q4 | $440K | Hold |
2,478
| – | – | 0.31% | 75 |
|
|
2024
Q3 | $489K | Sell |
2,478
-25
| -1% | -$4.94K | 0.31% | 82 |
|
|
2024
Q2 | $429K | Sell |
2,503
-76
| -3% | -$13K | 0.3% | 87 |
|
|
2024
Q1 | $470K | Sell |
2,579
-50
| -2% | -$9.11K | 0.33% | 87 |
|
|
2023
Q4 | $407K | Buy |
2,629
+24
| +0.9% | +$3.72K | 0.32% | 90 |
|
|
2023
Q3 | $388K | Sell |
2,605
-110
| -4% | -$16.4K | 0.34% | 90 |
|
|
2023
Q2 | $366K | Buy |
2,715
+14
| +0.5% | +$1.89K | 0.31% | 92 |
|
|
2023
Q1 | $430K | Sell |
2,701
-97
| -3% | -$15.5K | 0.38% | 78 |
|
|
2022
Q4 | $452K | Sell |
2,798
-500
| -15% | -$80.8K | 0.43% | 63 |
|
|
2022
Q3 | $443K | Buy |
3,298
+473
| +17% | +$63.5K | 0.49% | 61 |
|
|
2022
Q2 | $433K | Hold |
2,825
| – | – | 0.48% | 61 |
|
|
2022
Q1 | $458K | Buy |
2,825
+100
| +4% | +$16.2K | 0.46% | 62 |
|
|
2021
Q4 | $369K | Buy |
+2,725
| New | +$369K | 0.37% | 73 |
|